← Open Payments lookup

CHERRY DEOLASO: Open Payments

NPI 1174030712 · CARLSBAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,200 in 52 payments from 13 companies in 2025. Trend: 2023 $823 · 2024 $769 · 2025 $1,200

Food & beverage: $1,019Education: $181
CompanyPaymentsAmount
GlaxoSmithKline, LLC.23$350
AstraZeneca Pharmaceuticals LP3$197
SANOFI-AVENTIS U.S. LLC2$164
Insmed, Inc.10$143
Boehringer Ingelheim Pharmaceuticals, Inc.4$108
Amgen Inc.2$56
GENZYME CORPORATION2$48
Viatris Specialty LLC1$30
Verona Pharma, Inc.1$29
Regeneron Healthcare Solutions, Inc.1$27

Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, AIRSUPRA, Arikayce, TEZSPIRE, JASCAYD, OFEV.

Industry payments across CA — which companies pay providers there.